Add-on Acquisition • Healthcare Services

Roche Molecular Systems Acquires IQuum

On June 16, 2014, Roche Molecular Systems acquired healthcare services company IQuum for 450M USD

Acquisition Context

This is Roche Molecular Systems’ 1st transaction in the Healthcare Services sector.
This is Roche Molecular Systems’ largest (disclosed) transaction.
This is Roche Molecular Systems’ 1st transaction in the United States.
This is Roche Molecular Systems’ 1st transaction in Massachusetts.

Explore All 4611 Add-on Acquisition Healthcare Services Deals - Search the Database Free

M&A Deal Summary
Date	June 16, 2014
Target	IQuum
Sector	Healthcare Services
Buyer(s)	Roche Molecular Systems
Deal Type	Add-on Acquisition
Deal Value	450M USD

Target Company

IQuum

Marlborough, Massachusetts, United States

IQuum is a privately held company focused on developing point of care offerings for the molecular diagnostics market.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Roche Molecular Systems

Pleasanton, California, United States

Category	Company
Founded	1991
Sector	Healthcare Services

DESCRIPTION

Roche Molecular Diagnostics (RMD) is a business area of Roche Diagnostics (Basel, Switzerland) that develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Healthcare Services	1 of 1
Type: Add-on Acquisition	1 of 1
State: Massachusetts	1 of 1
Country: United States	1 of 1
Year: 2014	1 of 1
Size (of disclosed)	1 of 1

Explore Related M&A Activity

Healthcare Services M&A - Add-on Acquisition M&A Deals - Massachusetts M&A - United States M&A - 2014 M&A